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FOCUS ON. . . Ubiquitin-related tumor suppressorsThe mini-review series on ubiquitin-related tumor suppressors
(TSs) continues the FEBS Letters ‘‘FOCUS ON. . .’’ serial on TS pro-
teins. Previous issues were covering LKB1/AMPK signaling [1–7]
and metastasis suppressors [8–12]. In the present issue, the focus
lies on proteins implicated in human cancers and tumorigenesis
through their ability to either interfere with or be part of the
ubiquitin system. In this context, Wang and Jiang [13] refer to
Mdm2, a mono-ubiquitin E3 ligase that by interacting with MdmX
is converted to a p53 poly-ubiquitin E3 ligase regulating p53 deg-
radation. A group of key factors, such as p53, p73, PolH and c-Myc,
involved in DNA damage response, is regulated by Pirh2 (p53-in-
duced RING-H2) protein also known as Rchy1. Jung et al. report
on Pirh2, which is found up- or down-regulated in different types
of cancer, and hence is implicated in either promoting or suppress-
ing tumor progression [14]. The neuroﬁbromatosis type 2 (NF2)
gene encodes merlin, a protein that has been shown to suppress
mitogenic signaling both at the plasma membrane and in the nu-
cleus. Zhou and Hahnemann discuss the function of merlin, that
while inhibiting signaling by integrins and receptor tyrosine ki-
nases in the nucleus, suppresses the E3 ubiquitin ligase CRL4DCAF1
to inhibit proliferation [15]. Finally, Wang et al. [16] review the F-
box and WD repeat domain-containing 7 (FBW7) protein, which
has been characterized as an onco-suppressor protein in human
cancers. FBW7 recruits the SCF (SKP1-CUL1-F-box protein) com-
plex to form a functional E3 ligase. Both the major substrates
and its upstream regulatory factors are discussed, highlighting
the essential role of FBW7 in carcinogenesis.
Due to their critical role in regulating important cellular
processes, complete understanding of the underlying mechanisms
of TS functions is pivotal to utilize TSs as promising cancer thera-
peutic targets. In one of the forthcoming issues, FEBS Letters will
continue to highlight the ubiquitin-related aspect of tumorigenesis
by further focusing on the gene products of REST, VHL, BECLIN and
H2BUB1.
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